Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
作者： Penelope Elizabeth Miller , James Dale Moyer
DOI:
关键词: Keratinocyte growth factor 、 Human cancer 、 Combined treatment 、 Epidermal growth factor 、 Growth factor receptor inhibitor 、 Epidermal growth factor receptor 、 EGFR inhibitors 、 Toxicity 、 Chemistry 、 Pharmacology
摘要: The present invention relates to compositions and methods for treating the epithelial toxicity caused by administering a human cancer patient an epidermal growth factor receptor (EGFR) inhibitor. pharmaceutical composition preferably comprises EGFR inhibitor keratinocyte (KGF) in pharmaceutically-acceptable carrier. method of treatment co-administering therapeutically effective amount KGF with
lens.org 参考文章(11)
Rodney Caughren Schnur, Lee Daniel Arnold, Alkynl and azido-substituted 4-anilinoquinazolines ,(2008)
X.-D. Yang, A. Jakobovits, Ping Wang, C. G. Davis, X.-C. Jia, J. R. F. Corvalan, Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Research. ,vol. 59, pp. 1236- 1243 ,(1999)
Middleton B. Floyd, Allan Wissner, Douglas B. Kitchen, Bernard D. Johnson, 4-aminoquinazoline EGFR Inhibitors ,(1997)
Leo C. Groenen, Edouard C. Nice, Antony W. Burgess, Structure-Function relationships for the EGF/TGF-α family of mitogens Growth Factors Journal. ,vol. 11, pp. 235- 257 ,(1994) , 10.3109/08977199409010997
Atsuko Yoneda, Masahiro Asada, Yuko Oda, Masashi Suzuki, Toru Imamura, Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity. Nature Biotechnology. ,vol. 18, pp. 641- 644 ,(2000) , 10.1038/76487
J. R. Woodburn, A. J. Barker, K. H. Gibson, S. E. Ashton, A. E. Wakeling, B. J. Curry, L. Scarlett, L. R. Henthorn, ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT Journal of Immunotherapy. ,vol. 20, pp. 408- ,(1997) , 10.1097/00002371-199709000-00044
Norman E. Wikner, Karen A. Persichitte, Jonathan B. Baskin, Larry D. Nielsen, Richard A.F. Clark, Transforming Growth Factor-β Stimulates the Expression of Fibronectin by Human Keratinocytes Journal of Investigative Dermatology. ,vol. 91, pp. 207- 212 ,(1988) , 10.1111/1523-1747.EP12464997
Helen E. Jones, Carol M. Dutkowski, Denise Barrow, Maureen E. Harper, Alan E. Wakeling, Robert I. Nicholson, New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145 International Journal of Cancer. ,vol. 71, pp. 1010- 1018 ,(1997) , 10.1002/(SICI)1097-0215(19970611)71:6<1010::AID-IJC17>3.0.CO;2-H
Pablo A. Jimenez, Dale Greenwalt, Donna L. Mendrick, Mark A. Rampy, Jeffrey Su, Kam H. Leung, Kevin M. Connolly, Keratinocyte growth factor-2 Birkhäuser, Basel. pp. 101- 119 ,(2002) , 10.1007/978-3-0348-8456-3_7
Regina Mae Housley, Charles Frederick Morris, Glenn Francis Pierce, Therapeutic uses of keratinocyte growth factor ,(1995)